A First-in-human, Dose Escalation and Indication Expansion Study of BNT3212 as Monotherapy or in Combination With BNT327 in Adults With Advanced Solid Tumors

Clinical trial NCT07147348 · RECRUITING

Trial details

NCT number: NCT07147348
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2025-08-27
Primary completion: 2027-11-01
Enrollment: 375

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.